Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rosanne Sprute

Showing results (41-50 of 65) with videos related to

Pageof 7
Sort By:
JMIR Research Protocols|May 26, 2025
Immunogenicity of COVID-19 Vaccination in Immunocompromised Patients (Auto-COVID-VACC): Protocol for Multicenter Prospective Noninterventional StudyLouise Marie Cremer, Ullrich Bethe, Peter Borchmann, et al.
Journal of Human Genetics|June 6, 2019
Novel mutations in KMT2B offer pathophysiological insights into childhood-onset progressive dystoniaHormos Salimi Dafsari, Rosanne Sprute, Gilbert Wunderlich, et al.
The Journal of Antimicrobial Chemotherapy|February 18, 2021
Invasive infections with Purpureocillium lilacinum: clinical characteristics and outcome of 101 cases from FungiScope® and the literatureRosanne Sprute, Jon Salmanton-García, Ertan Sal, et al.
European Journal of Cancer (Oxford, England : 1990)|October 17, 2020
Evidence-based management of COVID-19 in cancer patients: Guideline by the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO)Nicola Giesen, Rosanne Sprute, Maria Rüthrich, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 14, 2025
Gender differences in audience participation at infectious disease and microbiology conferences: a prospective observational studySarah Dellière, Danila Seidel, Valentine Marie Ferré, et al.
European Journal of Cancer (Oxford, England : 1990)|March 6, 2021
2021 update of the AGIHO guideline on evidence-based management of COVID-19 in patients with cancer regarding diagnostics, viral shedding, vaccination and therapyNicola Giesen, Rosanne Sprute, Maria Rüthrich, et al.
The Lancet. Oncology|April 2, 2026
Anti-infective vaccination strategies in patients with haematological malignancies or solid tumours: updated guideline of the Infectious Diseases Working Party of the German Society for Hematology and Medical OncologySibylle C Mellinghoff, Blasius Liss, Jannik Stemler, et al.
European Journal of Haematology|February 4, 2024
Hybrid immunity to SARS-CoV-2 in patients with chronic lymphocytic leukemiaSibylle C Mellinghoff, Sandra Robrecht, Rosanne Sprute, et al.
Expert Opinion on Investigational Drugs|June 3, 2022
Invasive candidiasis: investigational drugs in the clinical development pipeline and mechanisms of actionMartin Hoenigl, Rosanne Sprute, Amir Arastehfar, et al.
The Journal of Infectious Diseases|March 4, 2026
Treatment Monitoring and Outcome Prediction in Invasive Aspergillosis using Immunologic MarkersAna Pereira, Jennifer Scott, Andrei Sarlea, et al.
Pageof 7

Showing results (41-50 of 65) with videos related to

Sort By:
Pageof 7
JMIR Research Protocols|May 26, 2025
Immunogenicity of COVID-19 Vaccination in Immunocompromised Patients (Auto-COVID-VACC): Protocol for Multicenter Prospective Noninterventional StudyLouise Marie Cremer, Ullrich Bethe, Peter Borchmann, et al.
Journal of Human Genetics|June 6, 2019
Novel mutations in KMT2B offer pathophysiological insights into childhood-onset progressive dystoniaHormos Salimi Dafsari, Rosanne Sprute, Gilbert Wunderlich, et al.
The Journal of Antimicrobial Chemotherapy|February 18, 2021
Invasive infections with Purpureocillium lilacinum: clinical characteristics and outcome of 101 cases from FungiScope® and the literatureRosanne Sprute, Jon Salmanton-García, Ertan Sal, et al.
European Journal of Cancer (Oxford, England : 1990)|October 17, 2020
Evidence-based management of COVID-19 in cancer patients: Guideline by the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO)Nicola Giesen, Rosanne Sprute, Maria Rüthrich, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 14, 2025
Gender differences in audience participation at infectious disease and microbiology conferences: a prospective observational studySarah Dellière, Danila Seidel, Valentine Marie Ferré, et al.
European Journal of Cancer (Oxford, England : 1990)|March 6, 2021
2021 update of the AGIHO guideline on evidence-based management of COVID-19 in patients with cancer regarding diagnostics, viral shedding, vaccination and therapyNicola Giesen, Rosanne Sprute, Maria Rüthrich, et al.
The Lancet. Oncology|April 2, 2026
Anti-infective vaccination strategies in patients with haematological malignancies or solid tumours: updated guideline of the Infectious Diseases Working Party of the German Society for Hematology and Medical OncologySibylle C Mellinghoff, Blasius Liss, Jannik Stemler, et al.
European Journal of Haematology|February 4, 2024
Hybrid immunity to SARS-CoV-2 in patients with chronic lymphocytic leukemiaSibylle C Mellinghoff, Sandra Robrecht, Rosanne Sprute, et al.
Expert Opinion on Investigational Drugs|June 3, 2022
Invasive candidiasis: investigational drugs in the clinical development pipeline and mechanisms of actionMartin Hoenigl, Rosanne Sprute, Amir Arastehfar, et al.
The Journal of Infectious Diseases|March 4, 2026
Treatment Monitoring and Outcome Prediction in Invasive Aspergillosis using Immunologic MarkersAna Pereira, Jennifer Scott, Andrei Sarlea, et al.
Pageof 7